Direct-to-consumer (DTC) pricing for medications is making a splash. With DTC, drug manufacturers sell medications directly to patients instead of through a retail pharmacy or pharmacy benefit manager (PBM). This is a shift from the traditional pharmacy model. Some drugs, including those for weight management, now have a DTC model. Eli Lilly & Co. and…
The first biosimilar was approved in the U.S. in 2015. And now, just over 10 years later, the U.S. Food & Drug Administration (FDA) has approved an additional 81 biosimilars. In 2025 alone, the FDA approved 18 new biosimilars for a range of indications. However, only 73% of those approved biosimilars have been launched as of September 2025. Last year, the U.S. market size for biosimilars was estimated to be $22.59 billion….
What’s ahead in the GLP-1 market in 2026 The obesity rate has been increasing over time in the U.S. From August 2021 to August 2023, about 40% of American adults were considered obese. A recent study shows that these rates will continue to rise for about 20 more years. Complications related to obesity include heart…
From IRA implementation to the impacts of AMP Cap and biosimilar adoption, here are five market trends Gateway Health Partners is keeping an eye on as we head into 2026 and how we’re helping clients stay ahead as the market continues to evolve.
A recent headline announcing plans to transition commercial clients to a “rebate-free” model, passing previously negotiated drugs savings directly to members at the point of sale, marks yet another potential shift in the pharmacy landscape. The new proposed model underscores how quickly the industry is continuing to evolve and could reshape how plan sponsors, payers, employers, health plans, and health systems define value in 2026…
We are honored to be featured in MedHealth Outlook’s 2025 spotlight for our work helping clients navigate formulary and rebate management in today’s complex healthcare environment. Read the full article featuring Gateway’s President Miranda Yeager: Gateway Health Partners – Medhealth Outlook
Scott Webb, the Senior Vice President of Business Development at Gateway Health Partners, knows how to turn business goals into a reality. Read More
Miranda Yeager, Chief Client Officer is a seasoned professional with over two decades of experience driving innovation and excellence in healthcare. Read More
GHP’s A. Azim Bari, SVP, Clinical Services, is featured in the June edition of Healthcare Tech Outlook Magazine’s, Pharmacy Management Edition. Read More
Check out the feature with Maren Phillips, VP, Strategic Growth at Gateway Health Partners on this month’s publication of Healthcare Tech Outlook. Read More